Shares in the healthcare Goliath fell sharply following a report regarding asbestos-contaminated baby powder.
The e-commerce platform specialist just priced another secondary offering today. Here's what investors need to know.
An overall market sell-off and profit-taking after Thursday's big gain appeared to weigh on this health insurance platform stock.
The warehouse retailer slipped based on doubts following its earnings report.
After the short attack comes the stock buyback.
Traders cheer after the company provides an update on its bid to go private. Here's what investors need to know.
A buyer has come knocking on Belmond's door.
The streaming company settled a long-running tax dispute with Canada.
Investors aren't happy about the drugmaker's latest capital raise.
Investors are getting nervous about a detailed rebuttal to serious allegations that's taking longer than promised.
The company's struggling to make the shift to commercial-stage biotech, and recent news raises questions on when this will change.
Bad news for a rival pulled the Canadian marijuana producer down, too.
Investors are not pleased with the company's recently announced equity offering.
The health insurance platform company struck a deal with state regulators that pleased investors.
With no direct news around Ralph Lauren, this could be what's sending shares lower as the company heads into the holiday season.
Some investors need to brush up on their math.
UBS starts Monster stock at "sell."
First came the earnings warning. Now comes the short attack.
A guidance cut was the last thing investors wanted.
The data delivery specialist is pumping the revenue brakes in the fourth quarter, preparing for much bigger gains in 2019.